Shalamar Hospital

Menu
Menu
Dr. Abubaker Shahid

Dr. Abubaker Shahid

FCPS Oncology, Doctor of Philosophy (PhD) Radiotherapy and Oncology,
DMRT, Post-graduation in Radiotherapy & Medical Oncology FCPS in Radiation Oncology from College of Physicians & Surgeons
Visiting Medical Oncologist, Shalamar Institute of Medical Sciences, Lahore

About Dr. Abubaker Shahid

Dr. Abubaker Shahid is a highly accomplished oncologist with over three decades of experience in cancer care, research, and education. He holds numerous qualifications, including a PhD in Radiotherapy & Oncology, and is a recipient of the prestigious Pride Of Performance award in Oncology. Dr. Shahid’s expertise covers a wide range of cancer treatments, and his contributions to the field are evident through his extensive list of publications in renowned medical journals. He is also actively involved in teaching and training the next generation of oncologists. His remarkable career and dedication to advancing cancer care make him a prominent figure in the global fight against cancer.

Visiting Medical Oncologist at Shalamar Institute of Health Sciences, Lahore

Vast experience of treating all types of malignancies utilizing Chemotherapy (including High dose & dose dense protocols) & Radiation. Working on almost all types of Radiotherapy equipment like Co-60  ,  LINAC , Deep X-Ray, Simulator , Treatment planning system etc

Dr. Abubaker Shahid’s research interests focus on optimizing cancer treatment, advancing radiopharmaceuticals, conducting clinical trials, understanding cancer epidemiology, exploring medical imaging, improving oncology education, and advocating for enhanced cancer healthcare policies.

  • Graduation (MBBS) from King Edward College Lahore –1986
  • House job in Surgery & Medicine 6 months each from1.1.1987 to 31.12.1987 Mayo Hospital, Lahore.
  • Training fellowship in Clinical Oncology from November 1993 to February 1994 at Christie Hospital, Manchester, U.K.
  • Training fellowship in Clinical Oncology & Medical Oncology at IGR Paris, France from October 1996 to December 1996.
  • DMRT, post-graduation in Radiotherapy & Medical oncology from Postgraduate Medical Institute and Punjab University, Lahore 1989.
  • PhD in Radiotherapy & Oncology from Punjab University, Lahore 2011.
  • FCPS in Radiation Oncology from College of Physicians & Surgeons Pakistan 2022.
  • Brochogenic Carcinoma Review of 50 Cases presented at Conference of Pakistan Radiological Society1990 Lahore
  • Thyrotoxicosis treatment by I-131 in Pakistan Radiological Society Conference Rawalpindi, 1995.
  • Post Mastectomy Radiotherapy in Breast Cancer, Shaukat Khanum Conference Lahore, 1999.
  • An experience with Femara at INMOL Pakistan Radiological Society Conference, Peshawar 1999.    
  • Sandostatin in Hypatocelular Ca presented at Novartis Conference in Burban, Karachi and Society of Surgeons Lahore.
  • Gemcitabain in NSCLC at CPC Gulab Devi Hospital Lahore.
  • Multiple myeloma, three years experience at INMOL at Pakistan Society of Clinical Oncology Meeting Faisalabad and Pakistan Society of Hematology, Peshawar.
  • Hodgkin Disease experience at INMOL and Sheikh Zayed Hospital Lahore.
  • Post Mastectomy RT in Ca Breast at Krakow Poland and Madrid, Spain.
  • INMOL Experience in NPCa in Vienna IAEA meetjng.
  • AC-T in high risk Ca Breast, CRG study Peshawer, 2003.
  • Management of Bone mets Peshawer, PSCO, 2003.
  • Chemo Radiation with & without Brachytherapy boost in NPCa, IAEA Project meeting Cairo , December 2005 & PSCO meeting Faisalabad 2005.
  • Case Presentation Novartis Oncology meeting Istanbul Turkey August, 2005.
  • Case Presentation in Astra Zenica onco meeting December, 2006.
  • Case Presentation in Novartis Oncology meeting , Islamabad May, 2007.
  • Locally advanced breast cancer(LABC),CCL onco,Tashkent.
  • INMOL data on Ca Nasopharynx with & without Brachy boost at RCM , Vienna ,Oct, 2007.
  • Hypo fractionation in breast cancer , at AJM oncology meeting, Pataya Thailand August 2008.
  • An overview of breast cancer at Astra-Zenica meeting Islamabad & AJM meeting Thailand 2008.
  • Weekly paclitaxel in breast cancer, at Cipla oncology meeting, Malysia.
  • Gemcitabine in metastatic breast cancer, ATCO oncology symposium, Kualalumpur, Malysia, Dec , 2010.
  • Everolimus in Renal cell ca, year end oncology meeting by Novartis, Bali Indonesia, Dec 22-24 , 2011.
  • Started the Project “Post Mastectomy Radiotherapy in Breast Cancer, A comparison of three protocols” with the co-operation of IAEA in July 1998. Attended the project meetings in Poland 1998 & Spain 2000 and presented the data and follow up of 60 Cases. The project was then recommended for multi centric trial by the agency.
  • Worked as chief  investigator of IAEA multi –institutional Project on Nasopharyngeal carcinoma with & without Brachytherapy boost
  • Conducted the research trial in high risk operable breast cancer (AC-T) with Cancer Research Group of Pakistan
  • Started a project in advanced colorectal cancer with Irinotecan in collaboration with CRG.
  • Participated in a trial on Bronchogenic ca (PLUS-1) designed by Eli-Lilly.
  • Participated in a multi institutional trial on Induction chemo followed by Erlotinib maintenance in NSCLC.
  • Worked as chief investigator of IAEA , PERTAIN multi centric study for PET guided NSCLC tumour delineation.
  • International Oncology Conference SKMT February, 1999 Lahore.
  • American Society of Clinical Oncology ASCO, New Orleans, USA May, 2000.
  • Paclitaxel International Moot January, 2002 Bangkok, Thailand.
  • American Society of Clinical Oncology ASCO, Florida, USA May, 2002.
  • Pakistan Society of Clinical Oncology Meeting Karachi, Pakistan December, 2002.
  • International Lung & Breast Cancer Update Meeting Bangkok, Thailand February, 2003.
  • Ebewe Breast Cancer Meeting Salzburg, Austria June, 2003.
  • SKMT Cancer Conference October 2003, Dubai.
  • IAEA Project meeting NPCa, Vienna December, 2003.
  • PSCO International Cancer Conference, Peshawar, 2003.
  • ASCO Conference USA, 2004.
  • Eli Lilly RCM, Malaysia, March, 2004.
  • Novartis Onco Meeting Cairo, August, 2004.
  • Middle East ONCO Meeting Feb, 2005, Jordan.
  • Regional RCM, Eli Lilly, Feb, 2005, Hong Kong.
  • Roche Oncology update August, 2005, Zurich, Switzerland.
  • Novartis oncology symposium August 2005 Istanbul, Turkey.
  • IAEA, NPCa meeting December, 2005 Cairo.
  • ASCO meeting, 2006, Atlanta, USA.
  • Milan Breast Cancer Conference, Italy, 2007.
  • CCL Onco launch seminar Tashkent,sep 2007.
  • IAEA RCM on Ca Nasopharynx ,Vienna,23-25 Oct,2007.
  • ASCO 2008 Chicago , USA, June 2008.
  • International conference on malignant lymphomas Lugano Switzerland ,June 2008.
  • AJM oncology meeting August 2008 Thailand.
  • Saint Gallens breast cancer meeting, March 2009, Switzerland.
  • Cipla oncology meeting, Kualalumpur, Malysia,June, 2009.
  • ATCO oncology symposium, Kualalumpur, Malysia, Dec , 2010.
  • ESMO conference,Sep 2011, Stockholm,Sweden.
  • Novartis regional oncology conference, Dec 2011 Indonesia.
  • Asian oncology summit , April 2012 Singapore.
  • Europpean Cancer Conference 27th September to 1st Octobre 2013 Amsterdam Holland.
  • EBCC at Glasgow UK , March 2014.
  • IAEA PERTAIN study CRP meeting Vienna, July 2014.
  • IAEA Course on Thyroid Diseases, Beijing, China, June 2015.
  • ESMO Conference,Vienna, Austria, September, 2015.
  • IAEA project meeting on lung cancer , Vienna Austria, May 2016.
  • ESMO Conference, Copenhagen, Denmark,October 2016.
  • IAEA Scientific visit on Theranostics, Liverpool, UK, April, 2017.
  • EBCC, Barcelona, Spain, March, 2018.
  • IAEA project meeting Nov 2018, Vienna , Austria
  • Worked as Research Scholar in Atomic Energy Medical Centre ( CENUM) Mayo Hospital Lahore from 1st Jan, 1988 To 31st Dec, 1989.
  • Worked as a Senior Oncologist in Clinical Oncology at Institute of Radiotherapy & Nuclear Medicine (IRNUM), Peshawar from January 1990 to April 1991.
  • Worked at AEMC Mayo Hospital Lahore & Institute of Nuclear Medicine & Oncology (INMOL), Lahore as Senior Oncologist from April 1991 To 30 June 1996.
  • Worked at INMOL Lahore from 1.07.96 to 9.10.08 in Clinical Oncology. Promoted as Principle Oncologist on 1.12.98.
  • Worked at PINUM, Faisalabad as Director/Deputy Chief Oncologist from 16.10.08 to 31.08.12
  • Worked as Director/Chief Consultant at INMOL Lahore from 01.09.12 to 06.07.23.

 

  • Received Presidential civil award PRIDE OF PERFORMANCE in Oncology in 
  • Established first THERANOSTICS facility at INMOL in Pakistan.
  • Started MRI & PET based Radiotherapy simulations at INMOL for the first time in Pakistan.
  • Got INMOL recognised for five disciplenes for FCPS by CPSP.
  • Pakistan society of clinical oncology.
  • Cancer society of Pakistan.
  • Radiological Society of Pakistan.
  • Cancer Research Group of Pakistan.
  • Pakistan Islamic medical association.
  • Pakistan Medical Association.
    1. Bronchogenic Carcinoma A Review of 50 Cases in “The Cancer Research” Vol-1, No-1, Jan – March 1992.
    2. Osteogenic Sarcoma of Urinary Bladder- A Case Report. PJR, Vol -7 & 8, No-1 October – December 1996.
    3. Optimisation of I- 131 dosage in Thyrotoxicosis – A 50 Cases Study PJR Vol 9, No 1 & 2 1997.
    4. Three years experience of Multiple Myeloma at INMOL, Abstract book, PSCO Nov, 2001.
    5. Curative Aspiration of Thyroid Cysts, SJNM April, 2002.
    6. Multiple Myeloma – INMOL Experience, JPMA, Volume, 52, No-12, December 2003.
    7. New advances in the management of metastatic bone disease JPMA, Vol-53, No-12, Dec 2003.
    8. Sequential AC and Docetaxel adjuvant chemo & radiation in patients with high risk operable breast cancer. JPMA Vol-53, No-12, December 2003.
    9. Phase 2 study of adjuvant chemo with sequential AC & Docetaxel followed by radiation in high risk early breast cancer. Abstract No, 252-P, ESMO Nov, 2004.
    10. Concurrent AC-T with Radiation in high risks operable Ca Breast. Abstract No, 858 , ASCO -2005
    11. Stage 3 A&B Non small cell lung cancer , rationale of concomitant chemo radiotherapy followed by consolidation chemotherapy & PCI, Professional med J, Mar 2007;14(1), (181-186).
    12. Concomitant Chemo Radiation with & without Brachy therapy boost in advanced Ca Nasopharynx. Abstract book ONCO, 2008.
    13. Postmastectomy adjuvant radiation in breast cancer , A comparison of three hypofractionated protocols, vol 59,no 5, 2009,JPMA (282-287).
    14. Letter to editor, vol 59,No 9,2009,JPMA (657).
    15. Pattern of Distribution of Metastatic Lesions within Skeleton in Patients with Breast Carcinoma of Faisalabad and its Vicinity, Vol 3, No. 1, Jan – Jun 2009, APMC (13-17).
    16. Erlotinib in the treatment of Non Small Cell Lung Cancer ; A Case Report, Pakistan Postgraduate Medical Journal, Vol 20,No 4 Supp, Oct-Dec, 2009.
    17. Medical imaging registration: basic science & clinical implications , JAMC, Vol. 22, No. 2, Apr-Jun, 2010.
    18. Fight against cancer – Role of breast clinics, PIMA biennial convention souvenir ,9-10 ,March, 2011.
    19. Unusual presentation of mycosis fungoides as a lump in the scalp, Singapore medical journal 2011; 52(11):e1
    20. Antimicrobial peptides as infection imaging agents better than radiolabeled antibiotics. Akhtar MS, Imran MB, Nadeem MA and Shahid A.  Int J Pept. 2012; 2012:965238. Epub 2012 May 17.
    21. Chemo Radiation in colorectal carcinoma.Abstract book ONCO 2013 Faisalabad, page 46.
    22. Trends and Analysis of Cancer incidence of common male and female cancer in the population of Punjab Province of Pakistan during 1984-2014. Asian Pacific Journal of Cancer Prevention. Impact factor 2.54.
    23. Local and non local regularization techniques in emission (PET/SPECT) tomographic image reconstruction method. Journal of Digital Imaging , 01 June 2016, 29(3) 394-402,  Impact factor 1.4.
    24. In vivo evaluation of the bio-distribution of intravenously administered naked and functionalized silver nano particles in rabbit. Journal, IET Nanobiotechnology Vol 9, Issue 6, December 2015, p.368-374. Imact factor 1.723. 
    25. Irfan Ullah Khan, Abubaker Shahid, Fayyaz Ahmad, Ume K Dar, Munir Ahmad, Muhammad Javed, Studying the Biological Feasibility of [99mTc(CO)3]-Dextran-Cysteine-Cysteine-Mannose as a Potential Molecular Radiopharmaceutical for Sentinel Node Detection,Annals of Nuclear Medicine, Japan, January 2014. Annals of Nuclear Medicine 28(3) DOI: 10.1007/s12149-013-0802-9. Impact Factor of journal = 1.502.
    1. Irfan Ullah Khan, Abubaker Shahid, Fayyaz Ahmad, Ume Kalsoom Dar, Ijaz Ullah Khan, Muhammad Javed, Mahera Roohi, Synthesis, Radiolabeling and Bioevaluation of 99mTc (CO)3-Folate Azide Complex for Tumor Detection,Journal of the Chemical Society of Pakistan,December 2013, 35(6):1582-1587, Impact Factor of journal = 1.377. 
    1. Reference intervals for FT3 & FT4 in Pakistani euthyroid patients : effect of age & gender on thyroid function. JCPSP, 2014. Vol 24 (11) 806-809.
    1. Performance characteristics and evaluation of recently installed PET/CT Scanner at INMOL. Asia Oceana Journal Of Nuclear Medicine & Biology, vol 2, suppl 1, Non 2014.
    1. Finger dose measurement of of radiation workers at PET/CT Cyclotron center, Asia Oceana Journal Of Nuclear Medicine & Biology, vol 2, suppl 1, Non 2014. 
    1. Optimization of PET/CT Scanning for obese oncology patients , Asia Oceana Journal Of Nuclear Medicine & Biology, vol 2, suppl 1, Nov 2014.
    1. Comparison of Doxorubicin anticancer drug loading on different metal oxide nanoparticles. Medicine (Baltimore).2015 March,94(11): e 617 
    1. Irfan Ullah Khan, Abubaker Shahid, Ume Kalsoom Dar, Fayyaz Ahmad, Muhammad Javed, Development and Bioevaluation of Tc99m(CO)3-labeled 1-Azido-1-deoxy-B-D-glucopyranoside complex as a potential tumor-seeking agent; Pak J Phar Sci (2013), (Paper accepted, Acceptance letter attached), Impact Factor of Journal = 0.947.
    1. Brachytherapy boost in locoregionally advanced nasopharyngeal carcinoma : a prospective randomized trial of the International Atomic Energy Agency, Radiation Oncology 2014, 9:67
    1. Functioning Thyroid Nodules with Hypothyroidism in Hashimotos Thyroiditis, Pakistan Journal Of Radiology,Dec 2014;24(4):143-146
    1. Trends and Analysis of Cancer Incidence for Common Male and Female Cancers in the Population of Punjab Province of Pakistan during 1984 to 2014, Asian Pacific Journal of Cancer Preventionvol 16, 2015
    1. Mutations in Human Interferon alpha 2b Gene and Potential as Risk Factor Associated with Female Breast Cancer, Molecular Genetics & Genomics, 2016 july.
    1. Unusual Presentation Of Bone Metastases from Hepatocellular Carcinoma Mimicking as Breast Primary Lump, JCPSP, 2016.Vol.26 (8) : 710-711
    1. Isolated Dorsal Pancreatic Agenesis, JCPSP, Nov 2016, Vol 26, No.11 : 924-925.
    1. Prevalance and manifestations of thyroidal dysfunction in central Punjab Pakistan ( A case study), Sci.Int.(Lahore),28(4)3959-3963, 2016
    1. Multiparametric Ultrasound Imaging For Evaluation Of Breast Lesions, PJR, January – March 2017 ,Vol 27, No 1 : A 26.
    1. Smart Fusion Ultrasound Imaging : Emerging New Technology, PJR, January – March 2017, Vol 27, No 1:
    1. Annual Average Effective Dose Distribution & Analysis Of Lifetime Fatal & Lifetime Nonfatal Cancer Risks Among Pakistani Medical Staff, accepted Fuuast Journal Of Biology , Vol. 7 (1), June , 2017.
    1. Efficacy and Toxicity of concurrent chemoradiation in inoperable oral carcinoma in Pakistani population , JCPSP , June 2017, vol 27 , No.6.
    1. Studying the efficacy of escalated dose conformal radiation therapy in prostate carcinoma- Pakistani Experience, Journal of Chinese Medical Association, Nov 2017, Vol 80, No 11.
    1. Ultrasound Elastography : Improved characterization of breast lesions, PJR, Oct – Dec 2017, Vol 27, No 4.
    1. Duct ectasia in bilateral accessory axillary breasts: A case report,
    2. PJR, Oct – Dec 2017, Vol 27, No 4.
    1. Disease Characteristics and Treatment Outcome of Testicular Germ Cell Tumors Treated With Platinum Based Regimens : JCPSP , 2018, Vol .28 (4) 292-295
    1. Duct ectasia in bilateral accessory & unilateral normally located breast, A case report, Euoropean Journal Of Case Reports , EJMCR. 2018 ;2 ( May ) 2018: 68-71
    1. To study the response of locally advanced nasopharyngeal cancer to concurrent chemoradiotherapy , Kuwaiti Medical Journal , April 15 , 2019 , online published.
    1. High energy beams dosimetric intercomparison study at INMOL Lahore , Book of extended synopsis, International applications & quality assurance in medical radiation dosimetry, 18-21 June 2019, Vienna, Austria .
    1. Introducing FDG/PET-CT guided chemoradiotherapy for stage III NSCLC in low and middle income countries: preliminary results from the IAEA PERTAIN trial. Eur J Nucl Med Mol Imaging.2019;46(11):2235-2243
    1. Detection of Recurrence in Retromolar Trigone using “ Puffed Cheek “ F-18 PET-CT Scan. JPMA 2019 Sep;69(9):1403.
    1. Sonographically Guided Metallic Clip Placement For Tumour Localization In Early Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy , JPMA October 2019, Volume 69, Issue 10.
    1. Clinical application and emerging role of breast MRI, Pakistan Journal Of Radiology, October – December 2019, Volume 29- Number 4.
    1. Smokeless tobacco use and risk of oral cavity cancer , Turkish journal of medical sciences,( 2020 )50:291-297, TUBITAK doi10.3906/sag-1809-11
    1. Strain Elastography for Differntiation between Benign and Malignant Thyroid Nodules, JCPSP , April 2020 , Vol 30, No 4.
    1. Acute Side Effects With High Dose Rate Computed Tomography-guided Three-dimensional Brachytherapy in Carcinoma Cervix, JCPSP, June 2020, Vol 30, No 6
    1. The Role Of Preoperative Carcinoembryonic Antigen In Recurrence Of Resectable Colorectal Carcinoma, Acta Clin Croat 2020 ; 59:216-222 , September 2020
    1. Fever Of Unknown Origin: A Riddle Solved By 18F-FDG PET CT Scan , International Journal Of Medical Reviews & Case Reports (2020) 4(12):48-49
    1. Biodistribution of iron oxide stabilized Tc99m-Zr O2 nanoparticles in rabbit using honey as a capping agent- microwave assisted sol – gel approach , journal of sol-gel science & technology , published online 04 Mach 2021.
    1. Malignant Phyllodes Breast Tumour : A Rare Case Of Metastsasis in Skeletal Muscle Detected on Fluorodeoxyglucose Positron Emission Tomography. Cureus 13(5): e15274. DOI 10.7759/ cureus. 15274
    1. Recent Advances In Treatment And Radiation Therapy Of Breast Cancer : Archives Of Surgical Research, 2021, 2 (2):15-19
    1. Diagnostic accuracy of ultrasound in detection of pregnancy associated breast cancer : journal of shifa , jstmu / Vol 4.iss 1.113, JSTMU 2021 , 3
    1. Frequency of Induction Related Mortality in Patients of Acute Myeloid Leukemia – Experience From a Resource Limited Country : Asian Hematology Research Journal , 5(2): 21-30, 2021
    1. Clinical Practice Guidelines For The Management Of Colorectal Cancer , A Consensus Statement By The Society Of Surgeons & Oncology Society Of Pakistan , JPMA, Vol 71 No 10, supplement 6 ,October 2021.
    1. Tc-99m PSMA and LU-177 PSMA Theranostics Pair in a Patient of Metastatic Castration Resistant Prostate Cancer , JPMA, November 2021, Vol 71, Issue 11.
    1. Juvenile breast hyprrtrophy: report of two cases presenting with massive asymmetrical breast enlargement & palpable breast masses , European Journal of Medical Case Reports , Vol 5(10):296-300 , Nov 2021.
    1. PET-CT applications in lung cancer management , Abstract in Pakistan Journal Of Radiology , Nov 2021.
    1. Comparing High and Low Dose Radioiodine Therapy in Thyroid Remnant Ablation Among Intermediate and Low Risk Papillary Thyroid Carcinoma Ptients – Sigle Centre Experience , Dose Response SAGE Journals, December 2021.
    1. 18F-FES-PET-CTScan in Ptientsof Histopathologically Proven Esrogen Receptor Positive Breast Carcinoma at a Tertiary Care Facility, Journal of Advances in Medicine and Medical Research, Page 54-59, 1st April 2022.
    1. Inter-Observer Variability in the Interpretation of Ga 68- PSMA PET –CT Scan according to PROMISE Criteria , Advances in Molecular Imaging > Vol.12 No.1, January 2022
    1. Sentinel Lymph Node Mapping in Breast Cancer : Initial Expierence of a Multidisciplinary Team. Cureus 14(6) e25983 DOI 10.7759/cureus.25983
    1. Diagnostic value of strain elastography and shear wave elastography in differentiating benign and malignant breast lesions , ANN SAUDI MED 2022 , SEPTEMBER. OCTOBER
    1. Hypopharyngeal carcinoma with cutaneous metastases : A case report. Pakistan journal of Radiology, October – December 2022 , Volume 32. Number 4.
    1. Recurrent anaplastic meningioma with scalp metastases: A case report Pakistan journal of Radiology, October – December 2022 , Volume 32. Number
    1. Testicular implants ( multi sequential MRI ) – A rare ptcedure for cosmetic purposes , Pakistan journal of Radiology, October – December 2022 , Volume 32. Number 4.
    1. Influence Of Prognostic Group Classification of Advanced Male Germ Cell Tumor on Treatment Outcomes , Liaqat National Journal of Cancer Care 2022; 4(2): 28-33
    1. Comparison of Electrons and Photons Treatment Plans in Medulloblastoma Patients , Indonesian journal of cancer , Vol 17(1), 29-35 March 2023